TherapeuticsMD Company Profile (NYSEMKT:TXMD)

About TherapeuticsMD

TherapeuticsMD logoTherapeuticsMD, Inc. is a women's healthcare product company. The Company's segment is creating and commercializing products for women. It is focused on conducting clinical trials necessary for regulatory approval and commercialization of advanced hormone therapy pharmaceutical products. Its drug candidates are created using its SYMBODA hormone technology, which enables the administration of hormones with high bioavailability alone or in combination. The Company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter (OTC) vitamins. The Company's product line includes vitaTrue, vitaPearl, vitaMedMD Plus, vitaMedMD One Prenatal Multivitamin, vitaMedMD Plus Rx Prenatal Multivitamin, vitaMedMD One Rx Prenatal Multivitamin, vitaMedMD RediChew Rx Prenatal Multivitamin, vitaMedMD Iron 21/7, itaMedMD Menopause Relief with Lifenol Plus Bone Support, vitaMedMD Vitamin D3 50,000 IU, BocaGreenMD Prena1 Pearl and BocaGreenMD Prena1 Chew.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSEMKT
  • Symbol: TXMD
  • CUSIP:
Key Metrics:
  • Previous Close: $6.34
  • 50 Day Moving Average: $6.58
  • 200 Day Moving Average: $7.65
  • 52-Week Range: $196,492,000.00 - $5.56
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -23.04
  • P/E Growth: 0.00
  • Market Cap: $1.22B
  • Outstanding Shares: 196,492,000
  • Beta: 1.28
Additional Links:
Companies Related to TherapeuticsMD:

Analyst Ratings

Consensus Ratings for TherapeuticsMD (NYSEMKT:TXMD) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.50

Analysts' Ratings History for TherapeuticsMD (NYSEMKT:TXMD)
DateFirmActionRatingPrice TargetDetails
4/6/2016Jefferies GroupReiterated RatingBuy$18.00View Rating Details
4/4/2016Goldman Sachs Group Inc.Initiated CoverageBuy$10.00View Rating Details
2/28/2016Noble FinancialReiterated RatingBuy$18.00 -> $17.50View Rating Details
12/8/2015GuggenheimBoost Price TargetBuy$33.00View Rating Details
12/8/2015Stifel NicolausBoost Price TargetBuy$10.00 -> $14.00View Rating Details
(Data available from 10/24/2014 forward)


Earnings History for TherapeuticsMD (NYSEMKT:TXMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2016Q116($0.09)($0.11)$5.73 million$4.93 millionViewN/AView Earnings Details
2/25/2016Q415($0.10)($0.10)$5.33 million$5.63 millionViewListenView Earnings Details
11/4/2015Q315($0.12)($0.11)$5.01 million$5.19 millionViewN/AView Earnings Details
8/6/2015Q215($0.11)($0.16)$4.65 million$4.80 millionViewListenView Earnings Details
5/5/2015($0.10)($0.13)ViewN/AView Earnings Details
3/10/2015Q414($0.09)($0.10)$2.86 million$4.26 millionViewN/AView Earnings Details
11/6/2014Q3 14($0.08)($0.12)ViewN/AView Earnings Details
5/6/2014Q1 14($0.06)($0.06)$3.08 million$2.80 millionViewN/AView Earnings Details
3/3/2014Q213($0.06)($0.06)$2.72 million$2.90 millionViewN/AView Earnings Details
5/8/2013Q113($0.06)($0.06)$1.32 million$1.50 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for TherapeuticsMD (NYSEMKT:TXMD)
Current Year EPS Consensus Estimate: $-0.43 EPS
Next Year EPS Consensus Estimate: $-0.27 EPS


Dividend History for TherapeuticsMD (NYSEMKT:TXMD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for TherapeuticsMD (NYSEMKT:TXMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/11/2016Cooper C CollinsDirectorBuy16,000$6.23$99,680.00View SEC Filing  
8/25/2015Angus C RussellDirectorBuy13,500$5.98$80,730.00View SEC Filing  
6/8/2015Mitchell KrassanEVPSell30,000$8.18$245,400.00View SEC Filing  
5/12/2015Angus C RussellDirectorBuy35,000$6.15$215,250.00View SEC Filing  
5/11/2015Tommy G ThompsonChairmanBuy6,000$6.09$36,540.00View SEC Filing  
5/8/2015J Martin CarrollDirectorBuy10,000$6.11$61,100.00View SEC Filing  
11/21/2014Daniel A CartwrightCFOSell40,000$3.91$156,400.00View SEC Filing  
9/4/2014Tommy G ThompsonDirectorBuy1,757$5.44$9,558.08View SEC Filing  
6/5/2014Cooper C CollinsDirectorBuy20,000$3.84$76,800.00View SEC Filing  
5/9/2014Robert Lapenta, Jr.DirectorBuy5,000$3.66$18,300.00View SEC Filing  
5/8/2014Tommy ThompsonDirectorBuy14,000$3.57$49,980.00View SEC Filing  
3/26/2014Brian BernickDirectorSell421,268$6.70$2,822,495.60View SEC Filing  
3/26/2014John C.K. Iv MilliganInsiderSell353,412$6.70$2,367,860.40View SEC Filing  
3/26/2014Robert FinizioCEOSell982,053$6.70$6,579,755.10View SEC Filing  
3/10/2014Mitchell KrassanEVPSell7,500$7.73$57,975.00View SEC Filing  
2/26/2014John C.K. Iv MilliganPresidentSell25,000$6.31$157,750.00View SEC Filing  
2/21/2014Robert FinizioCEOSell50,000$6.17$308,500.00View SEC Filing  
2/12/2014Brian BernickDirectorSell31,250$6.16$192,500.00View SEC Filing  
1/30/2014John C.K. Iv MilliganInsiderSell25,000$6.16$154,000.00View SEC Filing  
1/23/2014Robert G FinizioCEOSell50,000$5.70$285,000.00View SEC Filing  
1/13/2014Mitchell KrassanEVPSell7,500$5.73$42,975.00View SEC Filing  
1/8/2014Brian BernickDirectorSell31,250$5.13$160,312.50View SEC Filing  
8/26/2013Brian BernickInsiderSell1,600,000$1.55$2,480,000.00View SEC Filing  
8/26/2013Jules A MusingDirectorBuy5,282$2.15$11,356.30View SEC Filing  
6/14/2013Cooper C CollinsDirectorSell2,631,579$1.75$4,605,263.25View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for TherapeuticsMD (NYSEMKT:TXMD)
News IconMovers to Watch For: Gentex Corp. (NASDAQ:GNTX), TherapeuticsMD, Inc. (NYSEMKT:TXMD) - The Newburgh Press (NYSEMKT:TXMD) - October 21 at 7:50 PM
News IconAnalyst Buzz: TherapeuticsMD, Inc. (NYSEMKT:TXMD) - FactsReporter (NYSEMKT:TXMD) - October 21 at 11:29 AM
News IconTrader's Buzzer – TherapeuticsMD, Inc.'s (TXMD) | Hot Stocks Point - Hot Stocks Point (NYSEMKT:TXMD) - October 21 at 11:29 AM
News IconNoteworthy Analyst Ratings of Two Stocks: TherapeuticsMD, Inc. (NYSEMKT:TXMD), Triumph Group, Inc. (NYSE:TGI) - The Voice Registrar (NYSEMKT:TXMD) - October 20 at 10:37 AM
News IconNew Analyst Ratings On TherapeuticsMD, Inc. (TXMD) - NewsDen (NYSEMKT:TXMD) - October 18 at 7:40 PM
News IconThe Key Numbers To Watch From TherapeuticsMD, Inc. (NYSEMKT ... - The Voice Registrar (NYSEMKT:TXMD) - October 18 at 7:40 PM
News IconBreakout Session Alert as Shares Pop BMO: TherapeuticsMD, Inc ... - Recall News (NYSEMKT:TXMD) - October 16 at 7:35 PM
News IconStock Vacillating Higher Pre-Bell: TherapeuticsMD, Inc. (:TXMD ... - Recall News (NYSEMKT:TXMD) - October 15 at 7:25 PM
News IconAnalyst Watch-list: Leidos Holdings, Inc. (NYSE:LDOS ... - Wall Street Times (press release) (NYSEMKT:TXMD) - October 14 at 7:41 PM
News IconLatest Analyst Ratings For TherapeuticsMD, Inc. (TXMD) - The De Soto Edge (NYSEMKT:TXMD) - October 13 at 11:48 AM logoImpax Laboratories : Research Reports on Drug Makers Equities -- Bristol-Myers Squibb, AstraZeneca, TherapeuticsMD, and Impax Laboratories (NYSEMKT:TXMD) - October 12 at 12:46 PM logoResearch Reports on Drug Makers Equities -- Bristol-Myers Squibb, AstraZeneca, TherapeuticsMD, and Impax Laboratories (NYSEMKT:TXMD) - October 12 at 12:46 PM
News IconTherapeuticsMD, Inc.'s (TXMD): Popular Mover to Observe - Hot Stocks Point (NYSEMKT:TXMD) - October 12 at 12:46 PM
News IconPay Close Attention To These Analyst Ratings Palatin Technologies ... - The Voice Registrar (NYSEMKT:TXMD) - October 11 at 9:14 AM
News IconTherapeuticsMD, Inc. (NYSEMKT:TXMD) Earnings Preview: Should ... - The Voice Registrar (NYSEMKT:TXMD) - October 5 at 7:40 PM logoMomentum Stocks: The Chemours Company (CC), TherapeuticsMD ... - iStreetWire (NYSEMKT:TXMD) - October 3 at 7:16 PM
News IconPay Close Attention To These Analyst Ratings TherapeuticsMD Inc (NYSEMKT:TXMD), Abercrombie & Fitch Co. (NYSE ... - The Voice Registrar (NYSEMKT:TXMD) - September 30 at 7:06 PM logoTherapeuticsMD Inc (NYSEMKT:TXMD)'s Other Candidate Could Be More Important Than Yuvvexy - Market Exclusive (NYSEMKT:TXMD) - September 28 at 7:36 PM logoTherapeuticsMD Inc (NYSEMKT:TXMD)’s Other Candidate Could Be More Important Than Yuvvexy (NYSEMKT:TXMD) - September 28 at 7:36 PM
News IconTime to Buy TherapeuticsMD Inc After Today's Huge Increase? - Post News (NYSEMKT:TXMD) - September 25 at 6:39 PM
News IconAnalysts' Recommendations Stocks in Focus: Sirius XM Holdings Inc. (NASDAQ:SIRI) & TherapeuticsMD Inc ... - Money News (NYSEMKT:TXMD) - September 23 at 7:12 PM
News IconTherapeuticsMD Announces Multiple Presentations Related to Yuvvexy (TX-004HR) at Two Upcoming Medical Conferences (NYSEMKT:TXMD) - September 22 at 7:29 PM
News IconHealthcare News Buzz in Analytic Views- Great Basin Scientific (NASDAQ:GBSN), TherapeuticsMD, Inc. (NYSE:TXMD) - Seneca Globe (NYSEMKT:TXMD) - September 21 at 7:20 PM
News IconSteelmaker Nucor to buy Chicago's Independence Tube for $435 million (NYSEMKT:TXMD) - September 21 at 5:43 AM
News IconFinancial Update of TherapeuticsMD, Inc. (AMEX:TXMD) - Newburgh Press (NYSEMKT:TXMD) - September 20 at 5:25 PM logoTherapeuticsMD (TXMD) Reports FDA Acceptance of Yuvvexy NDA - (NYSEMKT:TXMD) - September 19 at 7:44 PM logoNovember 18th Options Now Available For TherapeuticsMD (TXMD) (NYSEMKT:TXMD) - September 19 at 7:43 PM logoTherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for Yuvvexy™ (TX-004HR) (NYSEMKT:TXMD) - September 19 at 7:43 PM logoTHERAPEUTICSMD, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NYSEMKT:TXMD) - September 19 at 7:43 PM
News IconQuarterly Financial Watch for TherapeuticsMD, Inc. (AMEX:TXMD) - Newburg Press (NYSEMKT:TXMD) - September 16 at 11:26 AM
News IconStocks within Analyst Limelight: TherapeuticsMD, Inc. (NYSEMKT:TXMD) , BofI Holding, Inc. (NASDAQ:BOFI) - Wall Street Times (press release) (NYSEMKT:TXMD) - September 12 at 8:31 AM logoHere's Why TherapeuticsMD Inc. Fell 11.5% in August (NYSEMKT:TXMD) - September 12 at 8:13 AM
News IconShares Lower Over the Past Quarter: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD) - September 10 at 6:54 PM
News IconIt's Earnings Time: What to Do with TherapeuticsMD, Inc. (NYSEMKT:TXMD) Stock - The Voice Registrar (NYSEMKT:TXMD) - September 9 at 7:25 PM
News IconStock Sliding Down Over the Last Month: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD) - September 8 at 7:28 PM
News IconStock Struggling for the Quarter: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD) - September 3 at 6:50 PM
News IconTherapeuticsMD, Inc.'s (TXMD): Hot Watch to Target - Hot Stocks Point (NYSEMKT:TXMD) - September 2 at 10:03 AM
News IconShares Slipping Lower Over the Past Month: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD) - September 1 at 11:05 AM
News IconThe Key Numbers To Watch From TherapeuticsMD, Inc. (NYSEMKT:TXMD)'s Earnings - The Voice Registrar (NYSEMKT:TXMD) - August 30 at 7:43 PM
News IconHC Stocks Overview: HCA Holdings Inc (HCA), TherapeuticsMD Inc (NYSEMKT:TXMD) - share market updates (press release) (NYSEMKT:TXMD) - August 30 at 11:17 AM
News IconHealthcare Stocks in the Spotlight: TherapeuticsMD Inc (NYSEMKT ... - Post Registrar (NYSEMKT:TXMD) - August 23 at 12:30 PM
News IconStock Tracking Lower for the Quarter: TherapeuticsMD, Inc. (:TXMD) - Post News (NYSEMKT:TXMD) - August 20 at 11:54 AM logoTherapeuticsMD Becomes Oversold (TXMD) - Nasdaq (NYSEMKT:TXMD) - August 20 at 11:54 AM logoTherapeuticsMD Becomes Oversold (TXMD) (NYSEMKT:TXMD) - August 19 at 7:50 PM logoEdited Transcript of TXMD earnings conference call or presentation 4-Aug-16 8:30pm GMT (NYSEMKT:TXMD) - August 17 at 10:56 AM
News IconTop Earnings to Watch for: TherapeuticsMD, Inc. (NYSEMKT:TXMD) - The Voice Registrar (NYSEMKT:TXMD) - August 16 at 8:03 PM logoTherapeuticsMD (TXMD) Shares are Down -0.13% - Trade Calls (NYSEMKT:TXMD) - August 8 at 8:29 AM
News IconNotable Watch List: Amber Road Inc (NYSE:AMBR), TherapeuticsMD Inc (NYSEMKT:TXMD) - NYSE Journal (press release) (NYSEMKT:TXMD) - August 7 at 7:33 PM
News IconWatch List: Amber Road Inc (NYSE:AMBR), TherapeuticsMD Inc (NYSEMKT:TXMD) - NYSE Journal (press release) (NYSEMKT:TXMD) - August 7 at 9:56 AM logoGilder Gagnon Howe Co Lowers stake in TherapeuticsMD Inc (TXMD) - Trade Calls (NYSEMKT:TXMD) - August 5 at 8:12 PM


Last Updated on 10/24/2016 by Staff